Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:2438247.
doi: 10.1155/2017/2438247. Epub 2017 Jan 15.

Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis

Affiliations

Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis

Shi Tang et al. Mediators Inflamm. 2017.

Abstract

Background. Inflammation and fibrosis are the important pathophysiologic processes in diabetic nephropathy (DN). Maresin 1 is a potential anti-inflammatory lipid mediator, which has displayed powerful proresolving activities. Aim. We determine whether maresin 1 has protective effect on mouse glomerular mesangial cells (GMCs) induced by high glucose. Methods. We cultured GMCs stimulated by high glucose and categorized as follows: normal glucose group (5.6 mmol/L), high glucose group (30 mmol/L), mannitol group, maresin 1 intervention group (1, 10, and 100 nmol/L), maresin 1 and normal glucose group, and the N-acetylcysteine (NAC) intervention group (10 μmol/L NAC). After 24 h, the expression of ROS, NLRP3, caspase-1, procaspase-1, IL-1β, and pro-IL-1β was detected by western-blot, RT-PCR, and immunofluorescence. After 48 h, the expression of TGF-β1 and FN was detected by RT-PCR and ELISA. Results. Compared with normal glucose group, the expression of ROS, NLRP3, caspase-1, IL-1β, TGF-β1, and FN increased in high glucose group (P < 0.05), but it decreased after the treatment of maresin 1 in different concentrations. On the contrary, the expression of procaspase-1 and pro-IL-1β protein was restrained by high glucose and enhanced by maresin 1 in a dose-dependent manner (P < 0.05). Conclusion. Maresin 1 can inhibit NLRP3 inflammasome, TGF-β1, and FN in GMCs; it may have protective effect on DN by mitigating the inflammation and early fibrosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests regarding the publication of this paper.

Figures

Figure 1
Figure 1
The mRNA expression of NLRP3, caspase-1, and IL-1β in mesangial cells treated with 30 mmol/L glucose for different time. (a) RT-PCR strip chart for different time. NLRP3, caspase-1, and IL-1β mRNA increased significantly after 6 h, 12 h, 24 h, and 48 h of exposure to 30 mmol/L glucose. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group.
Figure 2
Figure 2
The mRNA and protein level of NLRP3, caspase-1, procaspase-1, IL-1β, and pro-IL-1β in each group. (a) RT-PCR detected the expression of NLRP3, caspase-1, and IL-1β mRNA after intervened by high glucose and maresin 1 for 24 h in GMCs, and the mRNA expression of NLRP3, caspase-1, and IL-1β increased in HG group significantly, but compared with HG group, it decreased obviously in M + HG group as a concentration-dependent manner of maresin 1. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group, #P < 0.05 versus HG group. (c) Western-blot detected the expression NLRP3, caspase-1, procaspase-1, IL-1β, and pro-IL-1β protein after intervened by high glucose and maresin 1 for 24 h in GMCs, and the protein expression of NLRP3, caspase-1, and IL-1β increased and procaspase-1 and pro-IL-1β decreased in HG group significantly, but compared with HG group, the protein expression of NLRP3, caspase-1, and IL-1β decreased and procaspase-1 and pro-IL-1β increased obviously in M + HG group as a concentration-dependent manner of maresin 1. (d) The corresponding relative gray value statistics graph of the protein level. P < 0.05 versus NC group, #P < 0.05 versus HG group.
Figure 3
Figure 3
The level of NLRP3, caspase-1, and IL-1β in each group detected by immunofluorescence. The expression of NLRP3, caspase-1, and IL-1β increased in HG group significantly, but it decreased obviously in M3 + HG group, and there was no difference between NC group and NC + M3 group.
Figure 4
Figure 4
The level of NLRP3, caspase-1, P-caspase-1, IL-1β, and P-IL-1β in each group. (a) RT-PCR detected the expression NLRP3, caspase-1, and IL-1β mRNA after intervened by high glucose and 100 nmol/L maresin 1 in GMCs, and in HG group, the mRNA expression of NLRP3, caspase-1, and IL-1β was higher than that in NC group, but for M3 + HG group, the expression reduced visibly compared to the HG group. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group, #P < 0.05 versus HG group. (c) Western-blot detected the expression of NLRP3, caspase-1, P-caspase-1, IL-1β, and P-IL-1β protein after intervened by high glucose and 100 nmol/L maresin 1 in GMCs, and the protein expression of NLRP3, caspase-1, and IL-1β was higher than that in NC group, but for M3 + HG group, the expression reduced visibly compared to the HG group. The expression of P-caspase-1 and P-IL-1β was just the reverse. (d) The corresponding relative gray value statistics graph of the protein level. P < 0.05 versus NC group, #P < 0.05 versus HG group.
Figure 5
Figure 5
(a) DCFH-DA detected the expression of ROS in GMC after the treatment of NAC and maresin 1; P < 0.05 versus NC group, #P < 0.05 versus HG group. (b) GMCs were stained with DCFH-DA probe and images were captured using fluorescence microscope. Compared with NC group, the ROS generation increased in HG group, but it decreased in NAC + HG and M + HG group in a concentration-dependent manner.
Figure 6
Figure 6
The expression of TGF-β1 and FN in mesangial cells treated with 30 mmol/L glucose for different time. (a) RT-PCR strip chart for different time. Compared with NC group, the expression of TGF-β1 upregulated in HG group for different time, especially for 48 h. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group. (c) FN ELISA kit detected the level of FN in supernatant of GMCs treated with 30 mmol/L glucose for different time. Compared with NC group, the expression of FN upregulated in HG group for different time, especially for 48 h; P < 0.05 versus NC group.
Figure 7
Figure 7
The expression of TGF-β1 and FN in each group. (a) Expression of TGF-β1 in GMCs which were treated with different does of maresin 1 for 30 min and were exposed to high glucose (30 mmol/L) for 48 h. Compared with NC group, expression of TGF-β1 was significantly increased in HG group, and compared with HG group, expression of TGF-β1 was significantly lower in M + HG group, and there were effective changes in M2 + HG group. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group, #P < 0.05 versus HG group. (c) FN ELISA kit detected the level of FN in each supernatant of GMCs; we detected the similar change with TGF-β1; P < 0.05 versus NC group, #P < 0.05 versus HG group.
Figure 8
Figure 8
The level of TGF-β1 and FN in each group. (a) RT-PCR detected the expression of TGF-β1 mRNA after the treatment of maresin 1 for 48 h; compared with HG group, TGF-β1 mRNA was significantly decreased in M2 + HG group. (b) The corresponding relative gray value statistics graph of the mRNA level. P < 0.05 versus NC group, #P < 0.05 versus HG group. (c) FN ELISA kit detected the level of FN in supernatant of GMCs after the treatment of maresin 1; P < 0.05 versus NC group, #P < 0.05 versus HG group.

References

    1. Donath M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nature Reviews Drug Discovery. 2014;13(6):465–476. doi: 10.1038/nrd4275. - DOI - PubMed
    1. Kanwar Y. S., Sun L., Xie P., Liu F., Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual Review of Pathology: Mechanisms of Disease. 2011;6:395–423. doi: 10.1146/annurev.pathol.4.110807.092150. - DOI - PMC - PubMed
    1. Wada J., Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clinical Science. 2013;124(3):139–152. doi: 10.1042/CS20120198. - DOI - PubMed
    1. García-García P. M., Getino-Melián M. A., Domínguez-Pimentel V., Navarro-González J. F. Inflammation in diabetic kidney disease. World Journal of Diabetes. 2014;5(4):431–443. doi: 10.4239/wjd.v5.i4.431. - DOI - PMC - PubMed
    1. Tang S. C. W., Chan G. C. W., Lai K. N. Recent advances in managing and understanding diabetic nephropathy. F1000Research. 2016;5 doi: 10.12688/f1000research.7693.1.F1000 Faculty Rev-1044 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources